Menactra Solution for Injection

Manufacturer
SANOFI PASTEUR INC
 
Contents
Meningococcal (groups A, C, Y & W-135) polysaccharide diphtheria toxoid conjugate vaccine
 
Indication
Active immunization of individuals 9 mth-55 yr for prevention of invasive meningococcal disease caused by N meningitidis serogroups A, C, Y & W-135.
 
Instruction
Administer via IM Injection.
 
Drug interaction
Reduced immune response w/ immunosuppressive therapies eg, irradiation, antimetabolites, alkylating agents, cytotoxic drugs, corticosteroids.
 
 


 Inquiry - Menactra Solution for Injection